Douglas E. Albrecht

839 total citations
19 papers, 595 citations indexed

About

Douglas E. Albrecht is a scholar working on Molecular Biology, Physiology and Rehabilitation. According to data from OpenAlex, Douglas E. Albrecht has authored 19 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Physiology and 3 papers in Rehabilitation. Recurrent topics in Douglas E. Albrecht's work include Muscle Physiology and Disorders (16 papers), Adipose Tissue and Metabolism (5 papers) and Mitochondrial Function and Pathology (3 papers). Douglas E. Albrecht is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Adipose Tissue and Metabolism (5 papers) and Mitochondrial Function and Pathology (3 papers). Douglas E. Albrecht collaborates with scholars based in United States, Australia and France. Douglas E. Albrecht's co-authors include Stanley C. Froehner, James G. Tidball, Melissa J. Spencer, Plavi Mittal, Marvin E. Adams, Justin M. Percival, Bradley A. Williams, Laura Rufibach, Kristi Jones and Kathryn N. North and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Cell Science.

In The Last Decade

Douglas E. Albrecht

18 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas E. Albrecht United States 12 512 165 136 105 65 19 595
Alexandre Briguet Switzerland 11 539 1.1× 142 0.9× 120 0.9× 120 1.1× 37 0.6× 13 658
Virginie Jacquemin France 9 521 1.0× 148 0.9× 138 1.0× 87 0.8× 70 1.1× 11 611
Jaclyn P. Kerr United States 15 615 1.2× 145 0.9× 103 0.8× 211 2.0× 55 0.8× 19 783
Sabrina Batonnet‐Pichon France 12 636 1.2× 183 1.1× 98 0.7× 276 2.6× 60 0.9× 19 774
J.Rafael M. Gorospe United States 7 429 0.8× 161 1.0× 62 0.5× 67 0.6× 52 0.8× 8 497
Cíntia Yuri Matsumura Brazil 12 398 0.8× 131 0.8× 57 0.4× 91 0.9× 40 0.6× 22 510
Quan Q. Gao United States 15 649 1.3× 96 0.6× 98 0.7× 57 0.5× 67 1.0× 20 749
James S. Novak United States 14 599 1.2× 154 0.9× 68 0.5× 49 0.5× 92 1.4× 21 678
Eri Kondo-Iida Japan 8 842 1.6× 113 0.7× 209 1.5× 107 1.0× 99 1.5× 13 939
Patryk Konieczny Poland 14 734 1.4× 84 0.5× 221 1.6× 206 2.0× 67 1.0× 20 873

Countries citing papers authored by Douglas E. Albrecht

Since Specialization
Citations

This map shows the geographic impact of Douglas E. Albrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Albrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Albrecht more than expected).

Fields of papers citing papers by Douglas E. Albrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Albrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Albrecht. The network helps show where Douglas E. Albrecht may publish in the future.

Co-authorship network of co-authors of Douglas E. Albrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. Albrecht. A scholar is included among the top collaborators of Douglas E. Albrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. Albrecht. Douglas E. Albrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pajusalu, Sander, Nicole J. Lake, Geyu Zhou, et al.. (2019). Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. Genetics in Medicine. 21(11). 2512–2520. 57 indexed citations
2.
Gumerson, Jessica, Kimmo Lehtimäki, Jukka Puoliväli, et al.. (2017). Effect of Ibuprofen on Skeletal Muscle of Dysferlin-Null Mice. Journal of Pharmacology and Experimental Therapeutics. 364(3). 409–419. 3 indexed citations
3.
Potter, Rachael A., Danielle A. Griffin, R.W. Johnson, et al.. (2017). Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. Human Gene Therapy. 29(7). 749–762. 41 indexed citations
4.
Nonneman, Randal J., Natallia V. Riddick, Sheryl S. Moy, et al.. (2017). Hip region muscular dystrophy and emergence of motor deficits in dysferlin‐deficient Bla/J mice. Physiological Reports. 5(6). 21 indexed citations
5.
Albrecht, Douglas E., Laura Rufibach, Bradley A. Williams, et al.. (2013). 6th Dysferlin Conference, 3–6 April 2013, Arlington, Virginia, USA. Neuromuscular Disorders. 24(3). 277–287.
6.
Fuhrmann‐Stroissnigg, Heike, Irmgard Fischer, Douglas E. Albrecht, et al.. (2012). The Light Chains of Microtubule-Associated Proteins MAP1A and MAP1B Interact with α1-Syntrophin in the Central and Peripheral Nervous System. PLoS ONE. 7(11). e49722–e49722. 11 indexed citations
7.
Albrecht, Douglas E., et al.. (2011). 5th Annual Dysferlin Conference 11–14 July 2011, Chicago, Illinois, USA. Neuromuscular Disorders. 22(5). 471–477. 2 indexed citations
8.
Albrecht, Douglas E., et al.. (2011). 4th Annual Dysferlin Conference 11–14 September 2010, Washington, USA. Neuromuscular Disorders. 21(4). 304–310. 9 indexed citations
9.
Albrecht, Douglas E., et al.. (2009). 3rd Annual Dysferlin Conference 2–5 June 2009, Boston, Massachusetts, USA. Neuromuscular Disorders. 19(12). 867–873. 3 indexed citations
10.
Albrecht, Douglas E., Diane L. Sherman, Peter Brophy, & Stanley C. Froehner. (2008). The ABCA1 cholesterol transporter associates with one of two distinct dystrophin‐based scaffolds in Schwann cells. Glia. 56(6). 611–618. 17 indexed citations
11.
Compton, Alison G., Douglas E. Albrecht, Jane T. Seto, et al.. (2008). Mutations in Contactin-1, a Neural Adhesion and Neuromuscular Junction Protein, Cause a Familial Form of Lethal Congenital Myopathy. The American Journal of Human Genetics. 83(6). 714–724. 61 indexed citations
12.
Wang, Dongqing, et al.. (2007). Complete Deletion of All α-Dystrobrevin Isoforms Does Not Reveal New Neuromuscular Junction Phenotype. Gene Expression. 14(1). 47–57. 2 indexed citations
13.
Adams, Marvin E., et al.. (2007). Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed α-dystrobrevin. Journal of Cell Science. 121(1). 48–54. 22 indexed citations
14.
Percival, Justin M., et al.. (2006). γ-Syntrophin scaffolding is spatially and functionally distinct from that of the α/β syntrophins. Experimental Cell Research. 312(16). 3084–3095. 32 indexed citations
15.
Albrecht, Douglas E. & Stanley C. Froehner. (2004). DAMAGE, a Novel α-Dystrobrevin-associated MAGE Protein in Dystrophin Complexes. Journal of Biological Chemistry. 279(8). 7014–7023. 25 indexed citations
16.
Albrecht, Douglas E. & Stanley C. Froehner. (2002). Syntrophins and Dystrobrevins: Defining the Dystrophin Scaffold at Synapses. Neurosignals. 11(3). 123–129. 66 indexed citations
17.
Feng, Yupeng, Kun Yang, Yunqing Li, et al.. (2002). Croucher Advanced Study Institute (ASI) on Molecular Neuroscience. Neurosignals. 11(3). 158–174. 1 indexed citations
18.
Albrecht, Douglas E. & James G. Tidball. (1997). Platelet-derived Growth Factor-stimulated Secretion of Basement Membrane Proteins by Skeletal Muscle Occurs by Tyrosine Kinase-dependent and -independent Pathways. Journal of Biological Chemistry. 272(4). 2236–2244. 20 indexed citations
19.
Tidball, James G., et al.. (1995). Apoptosis precedes necrosis of dystrophin-deficient muscle. Journal of Cell Science. 108(6). 2197–2204. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026